---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-22-001588"
form_type: "8-K"
ticker: "TDOC"
cik: "0001477449"
company_name: "Teladoc Health, Inc."
filed_at: "2022-02-22T23:59:59+00:00"
generated_at: "2026-06-27T06:05:33.905024+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Teladoc Q4 revenue $554M (+45% YoY); 2022 guidance $2.55-2.65B

## Summary
- Q4 revenue $554.2M (+45% YoY); full year 2021 revenue $2.03B (+86% YoY).
- Q4 net loss improved to $0.07 per share from $3.07 loss; full year net loss $2.73 per share.
- Adjusted EBITDA Q4 $77.1M (+53% YoY); full year $267.8M (+111% YoY).
- 2022 revenue guidance $2.55-2.65B, representing 25-30% growth over 2021.
- Full year cash from operations $194.0M vs ($53.5M) prior year, a positive swing.

## SEC filing metadata
- accession: 0001558370-22-001588
- form_type: 8-K
- ticker: TDOC
- cik: 0001477449
- company_name: Teladoc Health, Inc.
- filed_at: 2022-02-22T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1477449/000155837022001588/0001558370-22-001588-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1477449/000155837022001588/tdoc-20220222x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-22-001588
- JSON: https://secwatch.observer/filing/0001558370-22-001588.json
- Plain text: https://secwatch.observer/filing/0001558370-22-001588.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.